Science & Technology
Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity
Department of Health and Human Services — National Institutes of Health
Opportunity #: 4R42DK135208-02
Award Ceiling
$2.0M
Award Floor
$2.0M
Close Date
Jul 31, 2025
Total Funding
$2.0M
Expected Awards
1
Posted Date
Aug 1, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-4R42DK135208-02
Description
STTR Phase Phase II award: "Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity" awarded to AQUALUNG THERAPEUTICS, CORP in JUNO BEACH, Florida. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,950,430. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.